Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-11
DOI
10.3389/fimmu.2021.719574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OPTN/SRTR 2019 Annual Data Report: Kidney
- (2021) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The NLRP3 inflammasome regulates corneal allograft rejection through enhanced phosphorylation of STAT3
- (2020) Chao Wei et al. AMERICAN JOURNAL OF TRANSPLANTATION
- HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation
- (2020) Venkat Giri Magupalli et al. SCIENCE
- Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
- (2019) Huahong Yang et al. Cell Communication and Signaling
- NLRP3: A promising therapeutic target for autoimmune diseases
- (2018) Hui-Hui Shen et al. AUTOIMMUNITY REVIEWS
- P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes
- (2018) Francesca D’Addio et al. JOURNAL OF CLINICAL INVESTIGATION
- How Inflammasomes Inform Adaptive Immunity
- (2018) Charles L. Evavold et al. JOURNAL OF MOLECULAR BIOLOGY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
- (2018) Ean-Jeong Seo et al. PHARMACOLOGICAL RESEARCH
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells
- (2018) Hyejin Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metabolic regulation of NLRP3
- (2017) Mark M. Hughes et al. IMMUNOLOGICAL REVIEWS
- Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells
- (2017) Zhuo Yao et al. Cell Death & Disease
- Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury
- (2017) Gan Zhao et al. Oncotarget
- Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia
- (2017) Huilin Huang et al. Scientific Reports
- Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection
- (2017) Joaquín Amores-Iniesta et al. Cell Reports
- Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound
- (2016) Dahong Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective effects of oridonin on the sepsis in mice
- (2016) Yan-Jun Zhao et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
- (2016) G. Arbore et al. SCIENCE
- Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms
- (2016) Min Shi et al. Oncotarget
- The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
- (2016) Petya Apostolova et al. Frontiers in Immunology
- Oridonin's therapeutic effect: Suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease
- (2015) Shubei Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- From immunosuppression to tolerance
- (2015) David H. Adams et al. JOURNAL OF HEPATOLOGY
- The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
- (2015) Mélanie Bruchard et al. NATURE IMMUNOLOGY
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Oridonin Attenuates Aβ1–42-Induced Neuroinflammation and Inhibits NF-κB Pathway
- (2014) Sulei Wang et al. PLoS One
- Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells
- (2013) Shengpeng Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Oridonin suppresses transplant rejection by depleting T cells from the periphery
- (2013) Wenzhi Guo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis
- (2013) Zhi-Yuan Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway
- (2013) Ke-Wang Sun WORLD JOURNAL OF GASTROENTEROLOGY
- Inflammasomes in health and disease
- (2012) Till Strowig et al. NATURE
- Sterile inflammatory responses mediated by the NLRP3 inflammasome
- (2010) Suzanne L. Cassel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
- (2010) Konrad Wilhelm et al. NATURE MEDICINE
- Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia
- (2009) Yan Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition
- (2008) Milka Sarris et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now